NPI: 1982728036 · CINCINNATI, OH 45211 · Clinical Medical Laboratory · NPI assigned 03/16/2007
Authorized official RALSTON, KIMBERLY controls 20+ related entities in our dataset. Read more
| Authorized Official | RALSTON, KIMBERLY (SYSTEM DIRECTOR) |
| NPI Enumeration Date | 03/16/2007 |
Other providers sharing the same authorized official: RALSTON, KIMBERLY
| Year | Claims | Total Paid |
|---|---|---|
| 2022 | 1,974 | $10K |
| 2023 | 152,456 | $1.07M |
| 2024 | 136,986 | $1.24M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 5,753 | 5,218 | $217K |
| 80053 | Comprehensive metabolic panel | 24,065 | 21,239 | $191K |
| 84443 | Thyroid stimulating hormone (TSH) | 18,679 | 16,265 | $171K |
| 80061 | Lipid panel | 20,198 | 17,470 | $143K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 21,043 | 18,291 | $105K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 8,256 | 6,811 | $101K |
| 36415 | Collection of venous blood by venipuncture | 30,108 | 25,139 | $83K |
| 83036 | Hemoglobin; glycosylated (A1C) | 16,085 | 13,712 | $69K |
| 87390 | 4,775 | 4,016 | $65K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1,479 | 1,310 | $50K |
| 87480 | 3,885 | 3,560 | $44K | |
| 87660 | 3,886 | 3,561 | $41K | |
| 86702 | 4,766 | 4,009 | $39K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 5,987 | 5,408 | $39K |
| 82607 | 5,564 | 4,451 | $38K | |
| 87510 | 3,886 | 3,561 | $38K | |
| 86701 | 4,772 | 4,017 | $34K | |
| 86803 | 4,114 | 3,408 | $33K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 771 | 729 | $32K |
| 80048 | Basic metabolic panel (calcium, ionized) | 4,487 | 4,036 | $30K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 2,036 | 1,923 | $30K |
| 84439 | 4,439 | 3,832 | $28K | |
| 82728 | 3,011 | 2,596 | $25K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 1,179 | 1,104 | $24K |
| 87563 | 1,144 | 1,026 | $24K | |
| 86780 | 2,825 | 2,417 | $23K | |
| 85027 | 5,123 | 4,603 | $22K | |
| 84403 | 1,502 | 1,316 | $22K | |
| 84153 | 2,024 | 1,733 | $22K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 818 | 708 | $20K |
| 82746 | 4,447 | 3,517 | $20K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 836 | 717 | $19K |
| 83550 | 3,807 | 3,226 | $18K | |
| 81514 | 295 | 293 | $18K | |
| 83540 | 3,946 | 3,348 | $17K | |
| 84270 | 1,208 | 1,058 | $16K | |
| 86480 | 537 | 471 | $16K | |
| 82570 | 3,958 | 3,588 | $16K | |
| 83880 | 724 | 652 | $14K | |
| 83001 | 1,165 | 1,029 | $14K | |
| 87522 | Neg quan hep c or qual rna | 892 | 727 | $12K |
| 87340 | 1,702 | 1,443 | $12K | |
| 82043 | 3,336 | 3,088 | $12K | |
| 83970 | 551 | 500 | $12K | |
| 84146 | 958 | 844 | $11K | |
| 87481 | 1,056 | 823 | $11K | |
| 87077 | 1,759 | 1,546 | $11K | |
| 86038 | 1,152 | 994 | $10K | |
| 80069 | 1,580 | 1,386 | $10K | |
| 87070 | 1,478 | 1,389 | $10K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 457 | 381 | $10K |
| 87186 | 1,658 | 1,511 | $9K | |
| 80076 | 1,639 | 1,411 | $9K | |
| 83735 | 2,004 | 1,703 | $8K | |
| 84702 | 895 | 671 | $8K | |
| 86762 | 931 | 778 | $8K | |
| 86850 | 840 | 697 | $8K | |
| 86140 | 1,787 | 1,453 | $8K | |
| 86696 | 743 | 623 | $7K | |
| 80050 | General health panel | 1,265 | 1,085 | $7K |
| 86706 | 879 | 762 | $7K | |
| 81001 | 2,481 | 2,202 | $6K | |
| 86787 | 715 | 605 | $6K | |
| 87808 | 875 | 780 | $6K | |
| 84481 | 642 | 560 | $6K | |
| 83002 | 538 | 473 | $6K | |
| 85652 | 2,550 | 2,073 | $5K | |
| 82670 | 319 | 272 | $5K | |
| 83516 | 639 | 494 | $5K | |
| 86695 | 664 | 563 | $5K | |
| 80074 | 351 | 263 | $4K | |
| 86431 | 835 | 713 | $4K | |
| 84703 | 679 | 599 | $4K | |
| 87088 | 635 | 586 | $3K | |
| 85610 | 1,151 | 919 | $3K | |
| 84550 | 979 | 876 | $3K | |
| 82627 | 235 | 199 | $3K | |
| 83690 | 732 | 648 | $3K | |
| 87081 | 551 | 522 | $3K | |
| 86900 | 876 | 726 | $3K | |
| 82533 | 257 | 198 | $3K | |
| 84144 | 247 | 186 | $3K | |
| 86901 | 876 | 726 | $3K | |
| 86003 | 54 | 31 | $3K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 123 | 84 | $3K |
| 86376 | 303 | 265 | $3K | |
| 82784 | 365 | 276 | $3K | |
| 84425 | 207 | 159 | $2K | |
| 86200 | 257 | 222 | $2K | |
| 82550 | 493 | 399 | $2K | |
| 82950 | 510 | 489 | $2K | |
| 84156 | 757 | 672 | $2K | |
| 84480 | 230 | 205 | $2K | |
| 86694 | 180 | 128 | $2K | |
| 83721 | 505 | 422 | $2K | |
| 82248 | 431 | 348 | $2K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 31 | 17 | $2K |
| 81003 | 739 | 649 | $2K | |
| 87205 | 423 | 379 | $1K | |
| 86735 | 159 | 133 | $1K | |
| 86765 | 162 | 134 | $1K | |
| 83013 | 29 | 26 | $1K | |
| 85730 | 496 | 394 | $855.03 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 65 | 55 | $833.60 |
| 84590 | 113 | 88 | $782.28 | |
| 83525 | 102 | 91 | $727.39 | |
| 86235 | 18 | 12 | $645.96 | |
| 84446 | 75 | 52 | $568.80 | |
| 84100 | 180 | 147 | $517.61 | |
| 82785 | 56 | 45 | $512.49 | |
| 84460 | 174 | 152 | $512.10 | |
| 87641 | 13 | 12 | $417.08 | |
| 86800 | 43 | 37 | $387.78 | |
| 84165 | 63 | 60 | $364.97 | |
| 84466 | 54 | 39 | $358.75 | |
| 85379 | 64 | 56 | $349.45 | |
| 82565 | 121 | 106 | $348.97 | |
| 86708 | 47 | 40 | $315.80 | |
| 86318 | 31 | 25 | $304.14 | |
| 82985 | 31 | 25 | $291.46 | |
| 82671 | 15 | 12 | $270.38 | |
| 86592 | 26 | 26 | $264.88 | |
| 87075 | 47 | 44 | $261.50 | |
| 84450 | 95 | 86 | $257.09 | |
| 82951 | 24 | 24 | $241.68 | |
| 83883 | 20 | 12 | $218.46 | |
| 86039 | 36 | 26 | $216.70 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 19 | 12 | $213.48 |
| 84630 | 15 | 15 | $189.05 | |
| 84155 | 64 | 61 | $161.28 | |
| 86704 | 27 | 24 | $150.87 | |
| 86225 | 18 | 12 | $142.24 | |
| 85045 | 53 | 41 | $123.18 | |
| G0475 | Hiv antigen/antibody, combination assay, screening | 215 | 145 | $115.19 |
| 82952 | 24 | 24 | $113.49 | |
| 82947 | 12 | 12 | $75.14 | |
| 83615 | 18 | 14 | $58.88 | |
| 81015 | 12 | 12 | $47.89 |